Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy - Trial NCT05800600
Access comprehensive clinical trial information for NCT05800600 through Pure Global AI's free database. This Phase 2 trial is sponsored by Fox Chase Cancer Center and is currently Recruiting. The study focuses on Anemia. Target enrollment is 34 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fox Chase Cancer Center
Timeline & Enrollment
Phase 2
Mar 15, 2023
Feb 01, 2026
Primary Outcome
Mean change from baseline to highest Hgb value
Summary
This is an open-label, single institution study evaluating the efficacy of intravenous iron
 sucrose monotherapy in patients with thoracic, breast, GU and GI malignancies undergoing
 neoadjuvant chemotherapy with the goal of undergoing surgical resection.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05800600
Non-Device Trial